Heart 1997;78:533-534 ( December )
Editorial
Minimally invasive direct coronary artery bypass: too young for a trial
| The first 150 words of the full text of this article appear below. |
Recently, a variety of novel approaches and ingenious techniques have been developed in an attempt to make cardiac surgical procedures less invasive.1 Many of these methods remain largely experimental, yet one procedure seems to have been rapidly accepted by cardiac surgeons. In minimally invasive direct coronary artery bypass (MIDCAB) the heart is approached via a right or left anterior mini-thoracotomy through which an internal mammary artery is harvested and anastomosed to the targeted coronary artery under direct vision without the use of cardiopulmonary bypass.2,3 Even though the MIDCAB procedure has been used for complex cases, the most common clinical use of MIDCAB has been for single vessel disease, predominantly involving the left anterior descending coronary artery. Indeed, several recent reports have claimed that the clinical outcome of patients managed with this approach is favourable.2-4
Not surprisingly, there are calls for randomised controlled trials of
MIDCAB against conventional revascularisation or angioplasty
This article has been cited by other articles:
-
SHARPLES, L D, CAINE, N, SCHOFIELD, P M, SHAPIRO, L M, DUNNING, J, WALLWORK, J
(1999). Randomised trials of new surgical procedures are necessary. Heart
81: 100-101
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
